Hindustantimes wants to start sending you push notifications. Click allow to subscribe

Covaxin good & bad news: US agency acclaim; Brazil deal suspension for probe

PUBLISHED ON JUN 30, 2021 06:46 PM IST
About The Video

  • India's first indigenous vaccine against Covid-19 - Covaxin - received international endorsement in the form of a study by the US National Institute of Health. The apex health agency said that Covaxin effectively neutralises Alpha and Delta variants of Sars-CoV-2 coronavirus. However, some not-so-good news followed for Bharat Biotech, Covaxin's developer. Brazil suspended a contract to procure the vaccine to probe allegations of irregularities in the deal - a charge denied by President Jair Bolsonaro. Watch the full video for more.



This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.